Elmazouni v. Mylan, Inc.

MEMORANDUM OPINION AND ORDER

BARBARA M. G. LYN, CHIEF JUDGE

Before the Court is a Rule 12(b)(6) Motion to Dismiss [ECF # 5], filed by Defendants Mylan, Inc., Mylan Pharmaceuticals, Inc., and Mylan Technologies, Inc. For the reasons stated, the Motion is GRANTED.

Background

This is a product liability action arising out.of the death of Lisa Elmazouni (“Decedent”), allegedly as a result of the toxic effects of fentanyl, a Schedule II controlled substance used for the treatment of persistent, chronic pain. PI. Compl. [ECF # 1] at 5, ¶¶ 4.03-4.04. Plaintiffs are Decedent’s husband, Abdelmajid…